MedPath
HSA Approval

DEPREVIX MODIFIED RELEASE HARD CAPSULE 75MG

SIN15520P

DEPREVIX MODIFIED RELEASE HARD CAPSULE 75MG

DEPREVIX MODIFIED RELEASE HARD CAPSULE 75MG

August 8, 2018

SEA PHARMA CONSULTANCY PTE LTD

SEA PHARMA CONSULTANCY PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSEA PHARMA CONSULTANCY PTE LTD
Licence HolderSEA PHARMA CONSULTANCY PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE, DELAYED RELEASE

ORAL

Medical Information

N06AX16

venlafaxine

Manufacturer Information

SEA PHARMA CONSULTANCY PTE. LTD.

Pharmathen S.A.

Pharmathen International S.A.

Active Ingredients

Venlafaxine Hydrochloride 84.86mg eqv Venlafaxine

75mg

Venlafaxine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEPREVIX MODIFIED RELEASE HARD CAPSULE 75MG - HSA Approval | MedPath